LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/offvsplacebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB)

Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Ulrike Krahn, Elisabeth Operschall, Eva Polverino, Kevin Winthrop, Robert Wilson
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.oa272

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1183/13993003.congress-2016.oa272

In partnership with: